Stock Chart
Stock Chart
-
Previous Close
-
Open0.027
-
Bid
-
Ask
-
Day's Range0.027 - 0.0324
-
52 week Range-
-
Volume40523
-
Avg. Volume
-
Market Cap
-
Beta (5Y Monthly)
-
PE Ratio (TTM)
-
EPS (TTM)
-
Earnings Date
-
Forward Dividend & Yield
-
Ex-Dividend Date
-
1y Target Est
KEEP ME INFORMED ON WSNAF UPDATES
WSNAF Performance
-
5 Day0%1 Month0%3 Month0%YTD0%1 Year0%
WSNAF on Twitter
-
Wed, Feb 8, 3:44 pm
-
Wed, Feb 8, 5:18 am
-
Tue, Feb 7, 4:13 pm
-
Tue, Feb 7, 4:11 pm
-
Tue, Feb 7, 11:01 am
-
Mon, Feb 6, 12:51 pm
-
Mon, Feb 6, 2:34 am
-
Sun, Feb 5, 4:54 am
-
Sun, Feb 5, 4:39 am
-
Sat, Feb 4, 8:46 pm
-
Sat, Feb 4, 2:13 pm
-
Sat, Feb 4, 12:29 pm
-
Sat, Feb 4, 11:44 am
-
Fri, Feb 3, 6:25 pm
-
Fri, Feb 3, 12:59 pm
WSNAF on iHub
WSNAF News
-
Fri, Dec 16, 5:00 pm
Wesana Health Announces Receipt of Short-Term Loan
-
Thu, Sep 1, 7:15 pm
Wesana Announces Sale of Clinic Management Services Organization
-
Mon, Aug 29, 8:00 pm
Wesana Announces Second Quarter 2022 Financial Results
-
Wed, Jun 15, 11:30 am
Fresh New Market Movers: Today’s Top Stock Picks for New & Trending Opportunities
-
Wed, Jun 8, 9:46 am
Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies
-
Tue, May 31, 5:30 pm
Wesana Announces First Quarter 2022 Financial Results
-
Tue, May 10, 7:30 am
Wesana Health Outlines Accelerated Drug Development Pathway
-
Thu, May 5, 9:09 am
Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets
-
Mon, May 2, 10:44 pm
Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights
-
Fri, Apr 29, 8:35 am
KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing
-
Wed, Apr 27, 8:35 am
Wesana Health to Present Live at KCSA Virtual Investor Conference April 28th
-
Mon, Apr 18, 6:34 pm
Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder
-
Tue, Mar 29, 7:30 am
Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events
-
Tue, Mar 22, 7:30 am
Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Anti-Depressant
-
Mon, Mar 14, 9:07 am
Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013
-
Fri, Mar 11, 5:00 pm
Wesana Provides Updates on Build-out of Third Clinic
Copyright © 2012. 007 Stock Chat, LLC